Holoclara

Series-A
holoclara.com Biotech & Healthcare
Total Funding $16M
Latest Round $16M Series-A
Last Announced Jun 27, 2024
Investors Undisclosed
Decision Makers 6 Verified

About Holoclara

We develop novel therapeutics derived from symbiotic organisms that modulate inflammation, metabolism, and tissue regeneration- core pathways that underlie chronic disease, resilience, and aging.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website holoclara.com
Domain Registered Date Jan 23, 2017

Social & Network Presence

X / Twitter Profile @Holoclara_Inc (26 followers) Created on Jun 2022
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $16,000,000 · Series-A

    fundraisingfox.com

  2. Milestone

    X account created (@Holoclara_Inc)

    26 followers

  3. Milestone

    Website domain registered

    holoclara.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Holoclara.

Funding History

1 Round
Series-A · Jun 27, 2024

Founders & Leadership

1

Andrea Choe

CEO / CO-FOUNDER

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts